How should we treat recurrent hepatitis C after liver transplantation?

Journal of Hepatology

Volumn 42, Issue 4, 2005, Pages 462-468

  Morard, Isabelle ^a   Negro, Francesco ^a,b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; PEGINTERFERON; RIBAVIRIN;

ASTHENIA; BONE MARROW TOXICITY; CLINICAL TRIAL; CYTOPENIA; DISEASE COURSE; GRAFT REJECTION; HEADACHE; HEPATITIS C; HUMAN; LIVER TRANSPLANTATION; MYALGIA; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SIDE EFFECT; TREATMENT OUTCOME;

EID: 14844299782     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.01.013     Document Type: Review

References (40)

1. L.M. Forman, J.D. Lewis, J.A. Berlin, H.I. Feldman, and M.R. Lucey The association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 122 2002 889 896
2. M. Berenguer, J. Crippin, R. Gish, N. Bass, A. Bustrom, and G. Netto A model to predict severe HCV-related disease following liver transplantation Hepatology 38 2003 34 41
3. P. Neumann, T. Berg, M. Bahra, G. Puhl, O. Guckelberger, and J.M. Langrehr Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up Transplantation 77 2004 226 231
4. C. Feray, D. Samuel, M. Gigou, V. Paradis, M.F. David, and C. Lemonnier An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection Hepatology 22 1995 1084
5. H.I. Wright, J.S. Gavaler, and D.H. Van Thiel Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients Transplantation 53 1992 121
6. T.L. Wright, C. Combs, M. Kim, L. Ferrell, P. Bacchetti, and N. Ascher Interferon-alpha therapy for hepatitis C virus infection after liver transplantation Hepatology 20 1994 773
7. A. Jain, A.J. Demetris, R. Manez, A.C. Tsamanadas, D. Van Thiel, and J. Rakela Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon Liver Transpl Surg 4 1998 197
8. E.J. Gane, S.K. Lo, S.M. Riordan, B.C. Portmann, J.Y.N. Lau, and N.V. Naoumov A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation Hepatology 27 1998 1403
9. T. Bizollon, U. Palazzo, C. Ducerf, M. Chevallier, M. Elliott, and J. Baulieux Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation Hepatology 26 1997 500
10. G. Gotz, M.R. Schon, A. Haefker, R. Neuhaus, U. Berg, and U. Hopf Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin Transplant Proc 30 1998 2104
11. D.V. Gopal, J.M. Rabkin, B.S. Berk, C.L. Corless, S. Chou, and A. Olyaei Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin Liver Transpl 7 2001 181 190
12. A.B. Alberti, L.S. Belli, A. Airoldi, L. de Carlis, G. Rondinara, and E. Minola Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study Liver Transpl 7 2001 870
13. K.V. Narayanan Menon, J.J. Poterucha, O.M. El-Amin, L.J. Burgart, W.K. Kremers, and C.B. Rosen Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy Liver Transpl 8 2002 623 629
14. J. Ahmad, S.F. Dodson, A.J. Demetris, J.J. Fung, and A.O. Shakil Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin Liver Transpl 7 2001 863 869
15. A.O. Shakil, B. McGuire, J. Crippin, L. Teperman, J. Demetris, and H. Conjeevaram A pilot study of interferon alfa and ribavirin combination inliver transplant recipients with recurrent hepatitis C Hepatology 36 2002 1253
16. D. Samuel, T. Bizollon, C. Feray, B. Roche, S.N. Si Ahmed, and C. Lemonnier Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study Gastroenterology 124 2003 642 650
17. B. Lavezzo, A. Franchello, A. Smedile, E. David, A. Barbui, and M. Torrani Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin J Hepatol 37 2002 247
18. R.J. Firpi, M.F. Abdelmalek, C. Soldevila-Pico, A. Reed, A. Hemming, and R. Howard Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C Liver Transpl 8 2002 1000 1006
19. E. Giostra, G.A. Kullak-Ublick, W. Keller, R. Fried, C. Vanlemmens, and S. Kraehenbuhl Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation Transpl Int 17 2004 169 176
20. W.B. Jolley, B. Sharma, R. Chami, C. Ng, and R. Bullington Long-term skin allograft survival by combined therapy with suboptimal dose of cyclosporine and ribavirine Transpl Proc 20 1988 703 706
21. N. Terrault, M. Khalili, S. Straley, K. Bollinger, N. Bass, and J.P. Roberts Efficacy and tolerability or preemptive interferon (IFN) versus IFN plus ribavirin treatment in hepatitis C virus (HCV) infected liver transplant recipients Hepatology 38 2003 158A
22. M. Charlton Preemptive treatment of recurrent hepatitis C infection Liver Transpl 8 2002 S50 S54
23. P.A. Sheiner, P. Boros, F.M. Klion, N.T. Swan, L.K. Schluger, and J.Y.N. Lau The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation Hepatology 28 1998 831 838
24. N. Singh, T. Gayowski, C.F. Wannstedt, F. Cheryl, A.O. Shakil, and M.M. Wagener Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial Transplantation 65 1998 82 86
25. C. Manzarbeitia, L. Teperman, N. Chalasani, P.A. Sheiner, R. Wiesner, and I. Marks Peginterferon alfa 2a (Pegasys) as prophylaxis against hepatitis C infection recurrence after liver transplantation (LT): preliminary results of a randomized, multicenter trial Hepatology 34 2001 406A
26. V. Mazzaferro, A. Tagger, M. Schiavo, E. Regalia, A. Pulvirenti, and M.L. Ribero Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment Transplant Proc 33 2001 1355 1357
27. C.A. Schirren, R. Zachoval, J.T. Gerlach, A. Ulsenheimer, N.H. Gruener, and H.M. Diepolder Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination J Hepatol 39 2003 397 404
28. T. Casanovas-Taltavull, M.G. Ercilla, C.P. Gonzalez, E. Gil, and O. Vinas Long-term immune response after liver transplantation in patients with spontaneous or post-treatment HCV-RNA clearance Liver Transpl 10 2004 584 594
29. R. Quadri, E. Giostra, T. Roskams, J.M. Pawlotsky, G. Mentha, and L. Rubbia-Brandt Immunological and antiviral effects of ribavirin in hepatitis C after liver transplant: a pilot study Transplantation 73 2002 373 378
30. M.S. Cattral, A.W. Hemming, I.R. Wanless, H. Al Ashgar, M. Krajden, and L. Lilly Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation Transplantation 67 1999 1277 1280
31. R.T. Stravitz, M.L. Shiffman, A.J. Sanyal, V.A. Luketic, R.K. Sterling, and D.M. Heuman Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation Liver Transpl 10 2004 850 858
32. T. Bizollon, S.N. Ahmed, S. Radenne, M. Chevallier, P. Chevallier, and P. Parvaz Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence Gut 52 2003 283 287
33. M.F. Abdelmalek, R.J. Firpi, C. Soldevila-Pico, A.I. Reed, A.W. Hemming, and C. Liu Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C Liver Transpl 10 2004 199 207
34. S. Mukherjee, R.K. Gilroy, T.M. McCashland, and D.F. Schafer Pegylated interferon for recurrent hepatitis C in liver transplant recipients with renal failure: a prospective cohort study Transplant Proc 35 2003 1478 1479
35. H. Rodriguez-Luna, A. Khatib, P. Sharma, G. De Petris, J.W. Williams, and J. Ortiz Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series Transplantation 77 2004 190 194
36. G.W. Neff, C.B. O'Brien, R. Cirocco, M. Montalbano, M. de Medina, and P. Ruiz Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing Liver Transpl 10 2004 595 598
37. A.S. Ross, A.K. Bhan, M. Pascual, M. Thim, A. Benedict Cosimi, and R.T. Chung Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C Clin Transplant 18 2004 166 173
38. J. Dumortier, J.Y. Scoazec, P. Chevallier, and O. Boillot Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination J Hepatol 40 2004 669 674
39. D.V. Gopal, and H.R. Rosen Duration of antiviral therapy for cholestatic HCV recurrence may need to be indefinite Liver Transpl 9 2003 348 353
40. G.L. Davis, J.E. Albright, S.F. Cook, and D.M. Rosenberg Projecting future complications of chronic hepatitis C in the United States Liver Transpl 9 2003 331 338